Evidence map›Paper›PMID 41372996›Full record

ArticleJournal of biological engineering2025

Enhanced methanol tolerance and utilization in Pichia pastoris revealed by adaptive laboratory evolution.

Junyeob Kim, Sang Woo Seo

Abstract read
In one paragraph

Article in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Junyeob KimSchool of Chemical and Biological Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
Sang Woo SeoSchool of Chemical and Biological Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea. swseo@snu.ac.kr.

Funding

National Research Foundation of Korea RS-2021-NR056596
6 · The paper itself

Abstract

backgroundMethanol is a promising renewable C1 feedstock for biomanufacturing. Native methylotrophs such as Pichia pastoris are considered potential chassis strains for methanol utilization. However, the cytotoxicity of methanol limits its usable concentration, posing a major bottleneck in bioproduction. In this study, we aimed to develop a P. pastoris strain with enhanced methanol tolerance and utilization by adaptive laboratory evolution.

resultsThrough serial passaging under increasing methanol concentrations, we obtained an evolved strain that exhibited a specific growth rate of 0.101 h− 1 in a 7% (v/v) methanol, a condition under which the wild-type strain failed to grow. Genome resequencing identified the mutations, and the introduction of individual mutations into the wild-type background demonstrated that mutations in PSR1 and BFA1 significantly improved growth under methanol stress. Notably, the fastest-growing isolate, designated PM7a, was capable of growing in a minimal medium containing 5% methanol as the sole carbon source, whereas the wild-type strain was unable to do so. Furthermore, the introduction of the β-carotene biosynthesis pathway into both the wild-type and PM7a strains, cultured in a minimal medium containing methanol as the sole carbon source, resulted in a 4.91-fold higher titer in PM7a.

conclusionsTaken together, our findings demonstrate that ALE facilitates the development of strains with enhanced methanol tolerance, growth, and biosynthetic performance. These findings highlight the potential of the evolved P. pastoris strain as a robust chassis for methanol-based biomanufacturing.

Indexed as

Adaptive laboratory evolutionMethanol utilizationPichia pastorisβ-carotene biosynthesis

Identifiers

PMID41372996
PMCPMC12801785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.